CA2091360A1 - Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques - Google Patents

Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques

Info

Publication number
CA2091360A1
CA2091360A1 CA2091360A CA2091360A CA2091360A1 CA 2091360 A1 CA2091360 A1 CA 2091360A1 CA 2091360 A CA2091360 A CA 2091360A CA 2091360 A CA2091360 A CA 2091360A CA 2091360 A1 CA2091360 A1 CA 2091360A1
Authority
CA
Canada
Prior art keywords
pharmaceutical compositions
mometasone furoate
making same
furoate monohydrate
monohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2091360A
Other languages
English (en)
Other versions
CA2091360C (fr
Inventor
Pui-Ho Yuen
Charles Eckhart
Teresa Etlinger
Nancy Levine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2091360(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2091360A1 publication Critical patent/CA2091360A1/fr
Application granted granted Critical
Publication of CA2091360C publication Critical patent/CA2091360C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
CA002091360A 1990-09-10 1991-09-06 Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques Expired - Lifetime CA2091360C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58023990A 1990-09-10 1990-09-10
US580,239 1990-09-10

Publications (2)

Publication Number Publication Date
CA2091360A1 true CA2091360A1 (fr) 1992-03-11
CA2091360C CA2091360C (fr) 1997-04-08

Family

ID=24320279

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002091360A Expired - Lifetime CA2091360C (fr) 1990-09-10 1991-09-06 Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques

Country Status (35)

Country Link
US (1) US6180781B1 (fr)
EP (1) EP0548114B1 (fr)
JP (1) JPH0725789B2 (fr)
KR (1) KR960013445B1 (fr)
CN (1) CN1030920C (fr)
AT (1) ATE113604T1 (fr)
AU (1) AU663471B2 (fr)
BG (1) BG60755B2 (fr)
CA (1) CA2091360C (fr)
CZ (1) CZ281318B6 (fr)
DE (2) DE19875032I2 (fr)
DK (1) DK0548114T5 (fr)
EE (1) EE02962B1 (fr)
ES (1) ES2065701T3 (fr)
FI (1) FI111078B (fr)
HK (1) HK185996A (fr)
HR (1) HRP920383B1 (fr)
HU (1) HU213401B (fr)
IE (1) IE67056B1 (fr)
IL (1) IL99437A (fr)
LU (1) LU90366I2 (fr)
MX (2) MX9203396A (fr)
MY (1) MY106644A (fr)
NL (1) NL980012I2 (fr)
NO (1) NO300548B1 (fr)
NZ (1) NZ239711A (fr)
OA (1) OA09772A (fr)
PH (1) PH30443A (fr)
PL (1) PL165803B1 (fr)
PT (1) PT98905B (fr)
SI (1) SI9111497A (fr)
TW (2) TW272195B (fr)
WO (1) WO1992004365A1 (fr)
YU (1) YU48666B (fr)
ZA (1) ZA917148B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19875032I2 (de) * 1990-09-10 2007-04-19 Schering Corp Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CN1059476C (zh) * 1996-08-21 2000-12-13 邓维鹏 金黄色铝合金硒盐电解着色方法
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
WO1999018971A1 (fr) * 1997-10-09 1999-04-22 Schering Corporation Suspensions de mometasone furoate pour la nebulisation
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
WO2005021515A2 (fr) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiesterase de type iv
WO2005051931A2 (fr) * 2003-11-26 2005-06-09 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiestérase
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
EP1934219A1 (fr) 2005-09-16 2008-06-25 Ranbaxy Laboratories Limited Pyrazolo[3,4-b]pyridines substituees en tant qu'inhibiteurs de la phosphodiesterase
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
CA2626612A1 (fr) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions pharmaceutiques d'antagonistes du recepteur muscarinique
JP2009512677A (ja) * 2005-10-19 2009-03-26 ランバクシー ラボラトリーズ リミテッド ホスホジエステラーゼタイプｉｖ阻害剤の組成物
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
US20100029728A1 (en) * 2006-09-22 2010-02-04 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
BRPI0717058A2 (pt) * 2006-09-22 2013-10-15 Ranbaxy Lab Ltd Composto, composição farmacêutica, método para tratar, prevenir, inibir ou suprimir uma condição inflamatória ou doença ou doenças do sistema nervoso central e método para a preparação de um composto
EP1958947A1 (fr) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiestérase de type 4
EP2124943A1 (fr) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Dérivés de pyrazolo[3,4-b]pyridine comme inhibiteurs de phosphodiestérases
ES2382715T3 (es) * 2007-03-14 2012-06-12 Ranbaxy Laboratories Limited Derivados de pirazol[3,4-B]piridina como inhibidores de fosfodiesterasa
EP2111861A1 (fr) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de type IV de la phosphodiestérase
CN105193773B (zh) 2009-05-29 2018-12-11 珍珠治疗公司 活性剂的呼吸递送
US8815258B2 (en) * 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
WO2014144894A1 (fr) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Procedes et systemes de conditionnement de matieres cristallines particulaires
CN107260671B (zh) * 2016-04-08 2021-03-26 天津金耀集团有限公司 一种糠酸莫米松混悬鼻喷剂组合物
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3260474D1 (en) * 1981-02-02 1984-09-06 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4783444A (en) 1984-09-17 1988-11-08 Schering Corporation Antiglaucoma compositions and methods
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
DE19875032I2 (de) * 1990-09-10 2007-04-19 Schering Corp Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
NL980012I2 (nl) 2004-11-01
YU149791A (sh) 1994-01-20
FI931031A0 (fi) 1993-03-09
AU8497491A (en) 1992-03-30
DE69104991D1 (de) 1994-12-08
JPH05506667A (ja) 1993-09-30
EP0548114A1 (fr) 1993-06-30
HU213401B (en) 1997-06-30
HRP920383B1 (en) 2000-04-30
US6180781B1 (en) 2001-01-30
NO300548B1 (no) 1997-06-16
CN1030920C (zh) 1996-02-07
CZ38393A3 (en) 1994-01-19
KR960013445B1 (ko) 1996-10-05
WO1992004365A1 (fr) 1992-03-19
IL99437A0 (en) 1992-08-18
PL165803B1 (pl) 1995-02-28
NO930693D0 (no) 1993-02-26
EP0548114B1 (fr) 1994-11-02
DK0548114T5 (da) 1995-01-30
TW272195B (fr) 1996-03-11
PT98905B (pt) 1998-08-31
ATE113604T1 (de) 1994-11-15
NO930693L (no) 1993-02-26
DE69104991T2 (de) 1995-04-20
MY106644A (en) 1995-07-31
EE02962B1 (et) 1997-02-17
HRP920383A2 (en) 1998-06-30
BG60755B2 (bg) 1996-02-29
FI111078B (fi) 2003-05-30
HUT64361A (en) 1993-12-28
PH30443A (en) 1997-05-09
AU663471B2 (en) 1995-10-12
IE67056B1 (en) 1996-02-21
LU90366I2 (fr) 1999-05-05
NZ239711A (en) 1992-09-25
NL980012I1 (nl) 1998-05-06
DE19875032I2 (de) 2007-04-19
ES2065701T3 (es) 1995-02-16
IE913155A1 (en) 1992-03-11
HK185996A (en) 1996-10-11
CN1059911A (zh) 1992-04-01
CZ281318B6 (cs) 1996-08-14
HU9300685D0 (en) 1993-06-28
MX9203396A (es) 1992-07-31
SI9111497A (sl) 1998-04-30
OA09772A (en) 1993-11-30
PT98905A (pt) 1992-09-30
YU48666B (sh) 1999-06-15
TW229208B (fr) 1994-09-01
CA2091360C (fr) 1997-04-08
MX9100990A (es) 1992-05-04
IL99437A (en) 1995-05-29
JPH0725789B2 (ja) 1995-03-22
FI931031A (fi) 1993-03-09
ZA917148B (en) 1992-08-26

Similar Documents

Publication Publication Date Title
CA2091360A1 (fr) Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
CA2111527A1 (fr) Phosphonooxymethylethers de derives du taxane
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
CA2152771A1 (fr) Derives 7-o-ether de taxane
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
IL99898A0 (en) 7-acyl-3-substituted carbamoyloxy cephem compounds,their preparation and antibacterial compositions containing them
EP0386920A3 (fr) Dérivés d'hydroxy-2-thiénylox-3-propylamine
ES8504166A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz(b,e) oxepina.
AU6263190A (en) Extracellular exopolymer, process for its preparation and pharmaceutical compositions containing the said exopolymer
AU6991291A (en) 3-l-(5-thioxo-l-prolyl) thiazolidine-4-carboxylic acid and derivatives therefrom, processes for the preparation thereof and pharmaceutical compositions containing them
AU3101593A (en) New pyridylsulphonylurea compound, processes for the preparation thereof, and pharmaceutical compositions containing it
ZA912180B (en) Novel compounds.cephalosporins,process for their preparation and pharmaceutical compositions containing them
AU7993982A (en) Tetra-peptide
AU3695393A (en) New arylpiperidine derivative, process for the preparation thereof and pharmaceutical compositions containing it
JO1711B1 (en) Therapeutic agents
IT1255696B (it) Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry